Skip to content
Tablet Allopathic

Insumin 500 mg tablet

Generic: Imeglimin Hydrochloride

Company: Eskayef Pharmaceuticals Ltd.. Prices are as listed on BestinMeds; your pharmacy price may differ.

Strength500 mg
PackStrip: 200.00 taka

Reviewed by: not listed yet. Source: not listed yet.

Last updated December 22, 2025.

Compare

Same generic, same strength

Sorted by price per tablet. Ask your pharmacist before you switch brands.

Imeglimin Hydrochloride 500 mg tablets

Prices as listed on BestinMeds.

2 brands listed
Insumin (this medicine)20.00 taka per tablet
Trimlin20.00 taka per tablet

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250
Medicine guide

About this medicine

What this medicine is for, how to take it, and what to watch for.

Read the full Imeglimin Hydrochloride guide

Indications

Imeglimin Hydrochloride tablet is used for the treatment of Type 2 Diabetes Mellitus as a monotherapy adjunct to diet and exercise.

Dosage and administration

In general for adults 2 tablets (1,000 mg) at a time, twice a day in the morning and evening. Below instructions should be followed strictly. If a dose is missed, the missed dose should be taken as soon as possible. However, if it is almost time for the next dose, the missed dose should be skipped and regular dosing schedule should be continued. Two doses should never be taken at one time. If more than prescribed dose taken accidentally, consult with your doctor immediately

Side effects

The most commonly reported side effects include nausea, diarrhea and constipation. Weakness, hungry feeling, sweating (hypoglycaemia) may also occur.

Precautions and warnings

This medicine may cause hypoglycemic symptoms. Therefore pay close attention while working at heights, drive a car, or operate dangerous machinery. If hypoglycemic symptoms occur, take sugar-containing foods or sugar. If you are taking alfa-glucosidase inhibitor (acarbose, voglibose, miglitol) in combination with this medicine, take glucose. Dosage reduction might be required for patients with renal impairment, eGFR

Pregnancy and lactation

Pregnancy: The safety of this product in pregnant women has not been established. Imeglimin should be used in pregnant women who may possibly be pregnant only if the expected therapeutic benefits outweigh the possible risks associated with treatment. Lactation: Breast-feeding must be discontinued during administration of this product in lactating women (transfer to milk in animal studies has been reported).

Clinical details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250